ArticleCancers2025

Validation of the International Medullary Thyroid Cancer Grading System and Identification of EZH2 as a Prognostic and Potential Therapeutic Marker in Medullary Thyroid Cancer.

Eline C Jager et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.